BIOX Relative Valuation
BIOX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BIOX is overvalued; if below, it's undervalued.
Historical Valuation
Bioceres Crop Solutions Corp (BIOX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 23.77. The fair price of Bioceres Crop Solutions Corp (BIOX) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 1.58 USD , Bioceres Crop Solutions Corp is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：1.58
Fair
Undervalued
0.00
PE
1Y
3Y
5Y
Trailing
Forward
7.11
EV/EBITDA
Bioceres Crop Solutions Corp. (BIOX) has a current EV/EBITDA of 7.11. The 5-year average EV/EBITDA is 10.08. The thresholds are as follows: Strongly Undervalued below 5.96, Undervalued between 5.96 and 8.02, Fairly Valued between 12.13 and 8.02, Overvalued between 12.13 and 14.19, and Strongly Overvalued above 14.19. The current Forward EV/EBITDA of 7.11 falls within the Undervalued range.
13.06
EV/EBIT
Bioceres Crop Solutions Corp. (BIOX) has a current EV/EBIT of 13.06. The 5-year average EV/EBIT is 14.07. The thresholds are as follows: Strongly Undervalued below 7.45, Undervalued between 7.45 and 10.76, Fairly Valued between 17.38 and 10.76, Overvalued between 17.38 and 20.69, and Strongly Overvalued above 20.69. The current Forward EV/EBIT of 13.06 falls within the Historic Trend Line -Fairly Valued range.
0.30
PS
Bioceres Crop Solutions Corp. (BIOX) has a current PS of 0.30. The 5-year average PS is 1.45. The thresholds are as follows: Strongly Undervalued below 0.34, Undervalued between 0.34 and 0.89, Fairly Valued between 2.00 and 0.89, Overvalued between 2.00 and 2.55, and Strongly Overvalued above 2.55. The current Forward PS of 0.30 falls within the Strongly Undervalued range.
2.07
P/OCF
Bioceres Crop Solutions Corp. (BIOX) has a current P/OCF of 2.07. The 5-year average P/OCF is 15.03. The thresholds are as follows: Strongly Undervalued below -56.32, Undervalued between -56.32 and -20.65, Fairly Valued between 50.70 and -20.65, Overvalued between 50.70 and 86.38, and Strongly Overvalued above 86.38. The current Forward P/OCF of 2.07 falls within the Historic Trend Line -Fairly Valued range.
2.48
P/FCF
Bioceres Crop Solutions Corp. (BIOX) has a current P/FCF of 2.48. The 5-year average P/FCF is 45.32. The thresholds are as follows: Strongly Undervalued below -168.82, Undervalued between -168.82 and -61.75, Fairly Valued between 152.38 and -61.75, Overvalued between 152.38 and 259.45, and Strongly Overvalued above 259.45. The current Forward P/FCF of 2.48 falls within the Historic Trend Line -Fairly Valued range.
Bioceres Crop Solutions Corp (BIOX) has a current Price-to-Book (P/B) ratio of 0.39. Compared to its 3-year average P/B ratio of 1.86 , the current P/B ratio is approximately -79.19% higher. Relative to its 5-year average P/B ratio of 3.32, the current P/B ratio is about -88.31% higher. Bioceres Crop Solutions Corp (BIOX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 4.68%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 1.75% , the current FCF yield is about -100.00% lower.
0.39
P/B
Median3y
1.86
Median5y
3.32
53.59
FCF Yield
Median3y
4.68
Median5y
1.75
Competitors Valuation Multiple
The average P/S ratio for BIOX's competitors is 0.00, providing a benchmark for relative valuation. Bioceres Crop Solutions Corp Corp (BIOX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -16.39%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BIOX decreased by 74.01% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -6.69 to -9.62.
The secondary factor is the Revenue Growth, contributed -16.39%to the performance.
Overall, the performance of BIOX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Bioceres Crop Solutions Corp (BIOX) currently overvalued or undervalued?
What is Bioceres Crop Solutions Corp (BIOX) fair value?
How does BIOX's valuation metrics compare to the industry average?
What is the current P/B ratio for Bioceres Crop Solutions Corp (BIOX) as of Dec 05 2025?
What is the current FCF Yield for Bioceres Crop Solutions Corp (BIOX) as of Dec 05 2025?
What is the current Forward P/E ratio for Bioceres Crop Solutions Corp (BIOX) as of Dec 05 2025?